
Since the program’s inception in 1992,
This is the second year Amgen has recognized science educators in
British Columbia
David Riendl, York House School in Vancouver, British Columbia
Alberta
Jane Diner, Old Scona Academic School in Edmonton, Alberta
Ontario
Glenn Wagner, Centre Wellington District High School in Fergus, Ontario
Quebec
Chantale Maheaux, Ecole secondaire de l'Horizon in Saint-Jean Chrysostome, Quebec
"We are thrilled to continue our sponsorship of the AASTE award. Our ongoing commitment to this awards program will help to acknowledge and reward remarkable teachers who continue to inspire and motivate students”, says Dr. Daniel Billen, Vice President and General Manager, Amgen
Along with the award applications, teachers were asked to submit an innovative science lesson plan which had been successfully introduced in their classroom. Amgen will post select winning lesson plans to its website to promote the sharing of this knowledge with educators across the country to bolster excellence and innovation in science teaching.
Applications are solicited every fall with winners selected based on the following criteria: innovative science lesson plan, creativity and effectiveness of teaching methods; and the plan for the use of grant money to improve science education resources in their schools.
As a leader in innovation, Amgen
2010 Applications
Applications for the 2010 awards will be available in the Fall of 2009 with a submission deadline of early 2010. The applications and further information about deadlines will be posted at http://www.amgen.com/citizenship/aaste.html.
About Amgen
Amgen discovers, develops and manufacturers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.ca.
CONTACT:
Natasha Bond
Amgen
(905) 285-3007
natasha.bond@amgen.com
Ethan Pigott
Hill and Knowlton
ethan.pigott@hillandknowlton.ca